These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37568191)

  • 1. Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies.
    Perfetto J; Yoo DA; Tamashiro CY; Perron MM; Vasquez-Canizares N; Wahezi DM
    Pediatr Rheumatol Online J; 2023 Aug; 21(1):82. PubMed ID: 37568191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies.
    Wahezi DM; Jerome D; Rothschild E; Yi B; Dvergsten J; Tarvin S; Kim S; Rubinstein T;
    Pediatr Rheumatol Online J; 2023 Sep; 21(1):100. PubMed ID: 37700267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies.
    Perron MM; Vasquez-Canizares N; Tarshish G; Wahezi DM
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):92. PubMed ID: 34118936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
    Shah M; Mamyrova G; Targoff IN; Huber AM; Malley JD; Rice MM; Miller FW; Rider LG;
    Medicine (Baltimore); 2013 Jan; 92(1):25-41. PubMed ID: 23263716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.
    Yamazaki K; Ohta A; Akioka S; Yamasaki Y; Ohara A; Nakaseko H; Nishimura K; Kobayashi N; Nishida Y; Sato S; Takezaki S; Kishi T; Hashimoto M; Kobayashi I; Mori M;
    Rheumatology (Oxford); 2021 Feb; 60(2):802-808. PubMed ID: 32810274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
    Melki I; Devilliers H; Gitiaux C; Bondet V; Duffy D; Charuel JL; Miyara M; Bokov P; Kheniche A; Kwon T; Authier FJ; Allenbach Y; Belot A; Bodemer C; Bourrat E; Dumaine C; Fabien N; Faye A; Frémond ML; Hadchouel A; Kitabayashi N; Lepelley A; Martin-Niclos MJ; Mudumba S; Musset L; Quartier P; Rice GI; Seabra L; Uettwiller F; Uggenti C; Viel S; Rodero MP; Crow YJ; Bader-Meunier B
    Rheumatology (Oxford); 2020 Aug; 59(8):1927-1937. PubMed ID: 31755959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.
    Conticini E; d'Alessandro M; Grazzini S; Fornaro M; Sabella D; Lopalco G; Giardina F; Colafrancesco S; Rizzo C; Guggino G; Priori R; Conti F; Iannone F; Bargagli E; Cantarini L; Frediani B
    Intern Emerg Med; 2022 Oct; 17(7):1921-1928. PubMed ID: 35754076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience.
    Kharouf F; Kenig A; Bohbot E; Rubin L; Peleg H; Shamriz O
    Clin Exp Rheumatol; 2023 Mar; 41(2):316-321. PubMed ID: 36826786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Idiopathic Inflammatory Myopathies.
    Huber AM
    Pediatr Clin North Am; 2018 Aug; 65(4):739-756. PubMed ID: 30031496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia.
    Alharbi M; Kazzaz YM; Hameed T; Alqanatish J; Alkhalaf H; Alsadoon A; Alayed M; Hussien SA; Shaalan MA; Al Johani SM
    J Infect Public Health; 2021 Apr; 14(4):446-453. PubMed ID: 33765595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic inflammatory myopathies: A clinicopathological study with emphasis on muscle histology.
    Challa S; Hui M; Jakati S; Uppin MS; Rajasekhar L; Kannan MA; Lingappa L; Jagarlapudi MMK
    Indian J Pathol Microbiol; 2019; 62(1):61-66. PubMed ID: 30706861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review.
    Abu-Rumeileh S; Marrani E; Maniscalco V; Maccora I; Pagnini I; Mastrolia MV; Rouster-Stevens K; Simonini G
    Autoimmun Rev; 2023 Oct; 22(10):103416. PubMed ID: 37611886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
    Scalabrini JC; Schiffenbauer AI; Farhadi PN; Volochayev R; Bayat N; Jansen A; Targoff IN; Miller FW; Rider LG
    Pediatr Rheumatol Online J; 2022 Apr; 20(1):28. PubMed ID: 35414090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies.
    Varnier GC; Consolaro A; Cheng IL; Silva Riveiro A; Pilkington C; Ravelli A
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI163-SI169. PubMed ID: 35929784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Preliminary Validation of an Electromyography-Scoring Protocol for the Assessment and Grading of Muscle Involvement in Patients With Juvenile Idiopathic Inflammatory Myopathies.
    Cappellari AM; Minoia F; Consonni D; Petaccia A; Picca I; Filocamo G
    Pediatr Neurol; 2021 Nov; 124():6-10. PubMed ID: 34507251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America.
    Sabbagh SE; Neely J; Chow A; DeGuzman M; Lai J; Lvovich S; McGrath T; Pereira M; Pinal-Fernandez I; Roberts J; Rouster-Stevens K; Schmeling H; Sura A; Tarshish G; Tucker L; Rider LG; Kim S;
    Rheumatology (Oxford); 2021 Feb; 60(2):829-836. PubMed ID: 32889531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).
    Jain M; Smith M; Cintas H; Koziol D; Wesley R; Harris-Love M; Lovell D; Rider LG; Hicks J
    Phys Occup Ther Pediatr; 2006; 26(3):5-17. PubMed ID: 16966313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.